AU6094794A - Non-denaturing potency assay for bovine somatotropin - Google Patents
Non-denaturing potency assay for bovine somatotropinInfo
- Publication number
- AU6094794A AU6094794A AU60947/94A AU6094794A AU6094794A AU 6094794 A AU6094794 A AU 6094794A AU 60947/94 A AU60947/94 A AU 60947/94A AU 6094794 A AU6094794 A AU 6094794A AU 6094794 A AU6094794 A AU 6094794A
- Authority
- AU
- Australia
- Prior art keywords
- bst
- bovine somatotropin
- polymer gel
- porous polymer
- size exclusion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 108010006025 bovine growth hormone Proteins 0.000 title claims description 209
- 238000003556 assay Methods 0.000 title description 14
- 238000000034 method Methods 0.000 claims description 71
- 238000003998 size exclusion chromatography high performance liquid chromatography Methods 0.000 claims description 59
- 102000004169 proteins and genes Human genes 0.000 claims description 48
- 108090000623 proteins and genes Proteins 0.000 claims description 48
- 239000000243 solution Substances 0.000 claims description 24
- 229920000642 polymer Polymers 0.000 claims description 18
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 claims description 15
- 229910000013 Ammonium bicarbonate Inorganic materials 0.000 claims description 15
- 235000012538 ammonium bicarbonate Nutrition 0.000 claims description 15
- 239000001099 ammonium carbonate Substances 0.000 claims description 15
- 239000002245 particle Substances 0.000 claims description 14
- 239000007853 buffer solution Substances 0.000 claims description 13
- 239000007864 aqueous solution Substances 0.000 claims description 10
- 239000011148 porous material Substances 0.000 claims description 9
- 230000005526 G1 to G0 transition Effects 0.000 claims description 4
- 108010051696 Growth Hormone Proteins 0.000 claims description 3
- 102000018997 Growth Hormone Human genes 0.000 claims description 3
- 238000011088 calibration curve Methods 0.000 claims description 3
- 241000283690 Bos taurus Species 0.000 claims description 2
- 235000018102 proteins Nutrition 0.000 description 44
- 239000012071 phase Substances 0.000 description 30
- 239000000523 sample Substances 0.000 description 16
- 230000000694 effects Effects 0.000 description 10
- 239000000499 gel Substances 0.000 description 10
- 238000010828 elution Methods 0.000 description 9
- 238000000926 separation method Methods 0.000 description 9
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 6
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 6
- 239000012062 aqueous buffer Substances 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 230000004044 response Effects 0.000 description 6
- 239000007790 solid phase Substances 0.000 description 5
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
- 230000004071 biological effect Effects 0.000 description 4
- 239000004202 carbamide Substances 0.000 description 4
- 230000007717 exclusion Effects 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 241000700159 Rattus Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 210000003000 inclusion body Anatomy 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 239000000178 monomer Substances 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 238000004007 reversed phase HPLC Methods 0.000 description 3
- 238000005185 salting out Methods 0.000 description 3
- 239000012488 sample solution Substances 0.000 description 3
- 230000004584 weight gain Effects 0.000 description 3
- 235000019786 weight gain Nutrition 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 108020004511 Recombinant DNA Proteins 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000006399 behavior Effects 0.000 description 2
- 239000013590 bulk material Substances 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000003398 denaturant Substances 0.000 description 2
- 230000003292 diminished effect Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 239000000122 growth hormone Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000012417 linear regression Methods 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 229950002069 somidobove Drugs 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000002211 ultraviolet spectrum Methods 0.000 description 2
- 239000003643 water by type Substances 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 206010062767 Hypophysitis Diseases 0.000 description 1
- 239000012901 Milli-Q water Substances 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- -1 aromatic amino acids Chemical class 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical class OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 210000003635 pituitary gland Anatomy 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 230000003381 solubilizing effect Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 108010057234 sometribove Proteins 0.000 description 1
- 229960000364 sometribove Drugs 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/26—Conditioning of the fluid carrier; Flow patterns
- G01N30/28—Control of physical parameters of the fluid carrier
- G01N30/34—Control of physical parameters of the fluid carrier of fluid composition, e.g. gradient
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/61—Growth hormone [GH], i.e. somatotropin
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/22—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising organic material
- B01J20/26—Synthetic macromolecular compounds
- B01J20/262—Synthetic macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. obtained by polycondensation
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/22—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising organic material
- B01J20/26—Synthetic macromolecular compounds
- B01J20/265—Synthetic macromolecular compounds modified or post-treated polymers
- B01J20/267—Cross-linked polymers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/28—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties
- B01J20/28002—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties characterised by their physical properties
- B01J20/28004—Sorbent size or size distribution, e.g. particle size
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/281—Sorbents specially adapted for preparative, analytical or investigative chromatography
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/281—Sorbents specially adapted for preparative, analytical or investigative chromatography
- B01J20/282—Porous sorbents
- B01J20/285—Porous sorbents based on polymers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/281—Sorbents specially adapted for preparative, analytical or investigative chromatography
- B01J20/291—Gel sorbents
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/50—Conditioning of the sorbent material or stationary liquid
- G01N30/52—Physical parameters
- G01N2030/524—Physical parameters structural properties
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
- G01N2030/8809—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
- G01N2030/8813—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials
- G01N2030/8831—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials involving peptides or proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Analytical Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- General Physics & Mathematics (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Dispersion Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US903493A | 1993-01-26 | 1993-01-26 | |
| US009034 | 1993-01-26 | ||
| PCT/US1994/000850 WO1994017403A1 (en) | 1993-01-26 | 1994-01-24 | Non-denaturing potency assay for bovine somatotropin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU6094794A true AU6094794A (en) | 1994-08-15 |
Family
ID=21735207
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU60947/94A Abandoned AU6094794A (en) | 1993-01-26 | 1994-01-24 | Non-denaturing potency assay for bovine somatotropin |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0681696A1 (da) |
| JP (1) | JPH08509288A (da) |
| KR (1) | KR960700454A (da) |
| CN (1) | CN1119042A (da) |
| AU (1) | AU6094794A (da) |
| BR (1) | BR9405672A (da) |
| CA (1) | CA2154794A1 (da) |
| CZ (1) | CZ193595A3 (da) |
| HU (1) | HUT75678A (da) |
| NO (1) | NO952948L (da) |
| PL (1) | PL310053A1 (da) |
| WO (1) | WO1994017403A1 (da) |
| ZA (1) | ZA94169B (da) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5567620A (en) * | 1993-01-26 | 1996-10-22 | Eli Lilly And Company | Non-denaturing potency assay for somatotropin |
| CN120685920A (zh) * | 2025-06-20 | 2025-09-23 | 浙江毓昌生物技术有限公司 | 一种牛生长激素体外相对生物活性检测方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4511502A (en) * | 1982-12-22 | 1985-04-16 | Genentech, Inc. | Purification and activity assurance of precipitated heterologous proteins |
| BG49718A3 (bg) * | 1983-07-15 | 1992-01-15 | Bio- Technology General Corp | Метод за получаване на полипептид със супероксиддисмутазна активност |
| US5079230A (en) * | 1988-09-12 | 1992-01-07 | Pitman-Moore, Inc. | Stable bioactive somatotropins |
| US5064943A (en) * | 1988-12-16 | 1991-11-12 | American Cyanamid Company | Method for solubilization and naturation of somatotropin |
| US4975529A (en) * | 1989-08-18 | 1990-12-04 | Monsanto Company | Method of folding somatotropins |
| US5047511A (en) * | 1989-08-28 | 1991-09-10 | Pitman-Moore, Inc. | Method for recovering recombinant proteins |
-
1994
- 1994-01-11 ZA ZA94169A patent/ZA94169B/xx unknown
- 1994-01-24 BR BR9405672A patent/BR9405672A/pt not_active Application Discontinuation
- 1994-01-24 CN CN94191402A patent/CN1119042A/zh active Pending
- 1994-01-24 AU AU60947/94A patent/AU6094794A/en not_active Abandoned
- 1994-01-24 EP EP94907307A patent/EP0681696A1/en not_active Withdrawn
- 1994-01-24 JP JP6517256A patent/JPH08509288A/ja active Pending
- 1994-01-24 PL PL94310053A patent/PL310053A1/xx unknown
- 1994-01-24 HU HU9502233A patent/HUT75678A/hu unknown
- 1994-01-24 CZ CZ951935A patent/CZ193595A3/cs unknown
- 1994-01-24 WO PCT/US1994/000850 patent/WO1994017403A1/en not_active Ceased
- 1994-01-24 CA CA002154794A patent/CA2154794A1/en not_active Abandoned
- 1994-01-24 KR KR1019950703075A patent/KR960700454A/ko not_active Withdrawn
-
1995
- 1995-07-25 NO NO952948A patent/NO952948L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HU9502233D0 (en) | 1995-09-28 |
| CN1119042A (zh) | 1996-03-20 |
| JPH08509288A (ja) | 1996-10-01 |
| CA2154794A1 (en) | 1994-01-24 |
| NO952948D0 (no) | 1995-07-25 |
| NO952948L (no) | 1995-09-18 |
| PL310053A1 (en) | 1995-11-13 |
| HUT75678A (en) | 1997-05-28 |
| EP0681696A4 (da) | 1995-11-22 |
| EP0681696A1 (en) | 1995-11-15 |
| KR960700454A (ko) | 1996-01-20 |
| CZ193595A3 (en) | 1996-05-15 |
| WO1994017403A1 (en) | 1994-08-04 |
| BR9405672A (pt) | 1995-11-14 |
| ZA94169B (en) | 1994-09-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Krummen et al. | The separation of nonapeptides by reversed-phase high-performance liquid chromatography | |
| Staub et al. | Intact protein analysis in the biopharmaceutical field | |
| US4377482A (en) | Mobile phase for liquid chromatography | |
| Takeuchi et al. | Enantiomeric resolution of dansyl amino acids by micro high-performance liquid chromatography with β-cyclodextrin inclusion complexes | |
| Grinberg et al. | Protein aggregation in high-performance liquid chromatography: hydrophobic interaction chromatography of. beta.-lactoglobulin A | |
| EP0206792B1 (en) | High performance liquid chromatography mobile phase | |
| Elrod Jr et al. | Determination of benzalkonium chloride in eye care products by high-performance liquid chromatography and solid-phase extraction or on-line column switching | |
| AU6094794A (en) | Non-denaturing potency assay for bovine somatotropin | |
| Thévenon et al. | Reversed-phase liquid chromatography of proteins with strong acids | |
| US5567620A (en) | Non-denaturing potency assay for somatotropin | |
| Lee et al. | Influence of the mobile phase on salmon calcitonin analysis by reversed-phase liquid chromatography | |
| Stuting et al. | Determination of pituitary and recombinant human growth hormone molecular weights by modern high-performance liquid chromatography with low angle laser light scattering detection | |
| Yang et al. | High-speed and high-performance size-exclusion chromatography of proteins on a new hydrophilic polystyrene-based resin | |
| Luo et al. | Preparation of monolithic imprinted stationary phase for clenbuterol by in situ polymerization and application in biological samples pretreatment | |
| Guitart et al. | Stability of phenyl (thiocarbamoyl) amino acids and optimization of their separation by high-performance liquid chromatography | |
| Goheen | The influence of pH and acetonitrile on the high performance size exclusion profile of proteins | |
| Bishop et al. | The Preparative Separation of Synthetic Peptides on Reversed-Phase Silica Packed in Radially Compressed Flexible-Walled Columns.+ | |
| Szabo et al. | High-performance liquid chromatography of proteins on stabilized polymer-diol-bonded silica-gel stationary phase | |
| Compton et al. | Chromatographic analysis of therapeutic proteins | |
| Lombardi et al. | Reverse phase high performance liquid chromatographic fractionation of marine organic matter | |
| Chang et al. | Non-denaturing assay for the determination of the potency of recombinant bovine somatotropin by high-performance size-exclusion chromatography | |
| Kelly et al. | Analysis of basic drugs by high-performance liquid chromatography using on-line solid-phase extraction and an unmodified silica column | |
| Wilson et al. | High-Performance Liquid Chromatography of Peptides and Proteins. Pharmaceutical and Bio-medical Applications | |
| Welinder et al. | Binding affinity of monoiodinated insulin tracers isolated after reversed-phase high-performance liquid chromatography | |
| CN113358763B (zh) | 一种高效液相色谱测定十二烷基肌氨酸钠含量的方法 |